The Lee and BDR decisions signal a shift in the landscape of compulsory licensing in India. This post examines the legal and policy developments leading to these outcomes, highlighting their implications for the Indian pharmaceutical industry.
Read more about Lee and BDR decision – the End of Compulsory Licenses?!Tag: Lee Pharma
Lee Pharma v. AstraZeneca- An unfinished Patent Story
This post examines the Lee Pharma v. AstraZeneca case on compulsory licensing under Indian patent law. The Controller’s decision sheds light on the standards for proving public need, affordable pricing, and working of patents in India.
Read more about Lee Pharma v. AstraZeneca- An unfinished Patent Story